146 related articles for article (PubMed ID: 23290252)
1. Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepines.
Kondaskar A; Kondaskar S; Fishbein JC; Carter-Cooper BA; Lapidus RG; Sadowska M; Edelman MJ; Hosmane RS
Bioorg Med Chem; 2013 Feb; 21(3):618-31. PubMed ID: 23290252
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.
Xie M; Lapidus RG; Sadowska M; Edelman MJ; Hosmane RS
Bioorg Med Chem; 2016 Jun; 24(12):2595-602. PubMed ID: 27134120
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship study of diaryl[d,f][1,3]diazepines as potential anti-cancer agents.
Yan L; Wang H; Chen Y; Li Z; Pei Y
Mol Divers; 2018 May; 22(2):323-333. PubMed ID: 29299857
[TBL] [Abstract][Full Text] [Related]
4. FeCl
Shiva Kumar K; Siddi Ramulu M; Rajesham B; Kumar NP; Voora V; Kancha RK
Org Biomol Chem; 2017 May; 15(20):4468-4476. PubMed ID: 28497830
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anticancer activities evaluation of novel 5H-dibenzo[b,e]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units.
He X; Li XY; Liang JW; Cao C; Li S; Zhang TJ; Meng FH
Bioorg Med Chem Lett; 2018 Mar; 28(5):847-852. PubMed ID: 29456106
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel thiazole-based 8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepines as potential antitumor and antifungal agents.
Ramírez J; Svetaz L; Quiroga J; Abonia R; Raimondi M; Zacchino S; Insuasty B
Eur J Med Chem; 2015 Mar; 92():866-75. PubMed ID: 25638570
[TBL] [Abstract][Full Text] [Related]
7. Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase.
Smith L; Wong WC; Kiselyov AS; Burdzovic-Wizemann S; Mao Y; Xu Y; Duncton MA; Kim K; Piatnitski EL; Doody JF; Wang Y; Rosler RL; Milligan D; Columbus J; Balagtas C; Lee SP; Konovalov A; Hadari YR
Bioorg Med Chem Lett; 2006 Oct; 16(19):5102-6. PubMed ID: 16887347
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
[TBL] [Abstract][Full Text] [Related]
9. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
Baccon-Sollier PL; Malki Y; Maye M; Ali LMA; Lichon L; Cuq P; Vincent LA; Masurier N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):935-949. PubMed ID: 32249633
[TBL] [Abstract][Full Text] [Related]
10. Microwave induced synthesis of novel 8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepines as potential antitumor agents.
Insuasty B; Orozco F; Quiroga J; Abonia R; Nogueras M; Cobo J
Eur J Med Chem; 2008 Sep; 43(9):1955-62. PubMed ID: 18222571
[TBL] [Abstract][Full Text] [Related]
11. A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring system.
Xie M; Ujjinamatada RK; Sadowska M; Lapidus RG; Edelman MJ; Hosmane RS
Bioorg Med Chem Lett; 2010 Aug; 20(15):4386-9. PubMed ID: 20594843
[TBL] [Abstract][Full Text] [Related]
12. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
13. Novel 4,5-dihydrospiro[benzo[c]azepine-1,1'-cyclohexan]-3(2H)-one derivatives as PARP-1 inhibitors: Design, synthesis and biological evaluation.
Li S; Li XY; Zhang TJ; Zhu J; Liu KL; Wang DP; Meng FH
Bioorg Chem; 2021 Jun; 111():104840. PubMed ID: 33780687
[TBL] [Abstract][Full Text] [Related]
14. Potent in vitro anticancer activities of ring-expanded ("fat") nucleosides containing the imidazo[4,5-e][1,3]diazepine ring system.
Gill JK; Wang L; Bretner M; Newman R; Kyprianou N; Hosmane RS
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1043-5. PubMed ID: 11562954
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of some diaryldiazepines and diarylpyrimidines.
Ramajayam R; Giridhar R; Yadav MR; Djaballah H; Shum D; Radu C
J Enzyme Inhib Med Chem; 2007 Dec; 22(6):716-21. PubMed ID: 18237024
[TBL] [Abstract][Full Text] [Related]
16. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxicity of novel imidazo[4,5-d]azepine compounds derived from marine natural product ceratamine A.
Pan X; Tao L; Ji M; Chen X; Liu Z
Bioorg Med Chem Lett; 2018 Mar; 28(5):866-868. PubMed ID: 29433924
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
Zhang N; Zhang P; Baier A; Cova L; Hosmane RS
Bioorg Med Chem Lett; 2014 Feb; 24(4):1154-7. PubMed ID: 24461293
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-one.
Maggio B; Raimondi MV; Raffa D; Plescia F; Cascioferro S; Cancemi G; Tolomeo M; Grimaudo S; Daidone G
Eur J Med Chem; 2015; 96():98-104. PubMed ID: 25874335
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydropyrrolo[3,2-c]azepin-4-ones as a new class of cytotoxic compounds.
Martínez R; Avila JG; Ramírez MT; Pérez A; Martínez A
Bioorg Med Chem; 2006 Jun; 14(12):4007-16. PubMed ID: 16504513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
